BRIEF published on 02/18/2026 at 07:35, 2 months 27 days ago Exail Technologies: Growth and Promising Prospects for 2026 Fundraising Financial Growth Maritime Robotics Navigation Systems Outlook 2026
BRIEF published on 02/18/2026 at 07:35, 2 months 27 days ago Exail Technologies annonce une forte croissance au quatrième trimestre 2025 Flexibilité Financière Exail Technologies Systèmes De Navigation Robotique Maritime Croissance Au Quatrième Trimestre
BRIEF published on 02/18/2026 at 07:35, 2 months 27 days ago Carrefour et Vusion : Partenariat pour le Magasin du Futur Partenariat Digitalisation Intelligence Artificielle Carrefour 2030 Technologie Magasin
BRIEF published on 02/18/2026 at 07:35, 2 months 27 days ago Carrefour Partners with Vusion to Digitize Stores by 2030 AI Technology Digitalization Retail Innovation Carrefour 2030 Vusion Partnership
BRIEF published on 02/18/2026 at 07:35, 2 months 27 days ago Carrefour and Vusion: Partnership for the Store of the Future Artificial Intelligence Partnership Digitalization Carrefour 2030 Technology Store
BRIEF published on 02/18/2026 at 07:35, 2 months 27 days ago Carrefour s'associe à Vusion pour numériser ses magasins d'ici 2030. Technologie IA Numérisation Innovation Dans Le Commerce De Détail Carrefour 2030 Partenariat Vusion
BRIEF published on 02/18/2026 at 07:35, 2 months 27 days ago GenSight Biologics Strengthens Regulatory Leadership with Key Appointments Gene Therapy Strategic Appointments GenSight Biologics Retinal Diseases Regulatory Leadership
BRIEF published on 02/18/2026 at 07:35, 2 months 27 days ago GenSight Biologics Renforce son Équipe Réglementaire Affaires Réglementaires GenSight Biologics Thérapies Géniques Nominations Clés Essai Phase III
BRIEF published on 02/18/2026 at 07:35, 2 months 27 days ago GenSight Biologics renforce son leadership réglementaire grâce à des nominations clés Thérapie Génique GenSight Biologics Maladies De La Rétine Nominations Stratégiques Leadership Réglementaire
BRIEF published on 02/18/2026 at 07:35, 2 months 27 days ago GenSight Biologics Strengthens its Regulatory Team Phase III Trial Regulatory Affairs Key Appointments GenSight Biologics Gene Therapies
Published on 05/16/2026 at 01:15, 1 day 18 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 20 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 20 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/16/2026 at 16:08, 1 day 4 hours ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 23 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 2 days 1 hour ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 2 days 5 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 5 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 9 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 11 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 4 days 2 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
